首页> 外文期刊>The American Journal of the Medical Sciences >Hemophagocytic Lymphohistiocytosis in the Elderly
【24h】

Hemophagocytic Lymphohistiocytosis in the Elderly

机译:老年人的血液活泼淋巴管激菌症

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hemophagocytic lymphohistiocytosis (HLH) is a rare disease of massive, dysregulated cytokine release and secondary multiorgan failure and is associated with high mortality. Primary HLH occurs predominately in infants and young children with a genetic predisposition. Acquired HLH is less well characterized and usually occurs in younger adults in the setting of severe inflammation triggered by infection or malignancy. Little is known about the disease in elderly. We report 3 patients 50 years old who presented with multiorgan failure and shock without an identifiable source and were ultimately diagnosed with acquired HLH. We performed a literature review of HLH in adults 50 years of age and identified an additional 68 cases. Mean age was 62 years, with male predominance. Most cases were triggered by infection (49%) followed by malignancy (27%). Nineteen patients were treated with the HLH-94 protocol, 11 received corticosteroids and the remainder received non-HLH specific interventions. Overall mortality was 62%.
机译:血小杂细胞淋巴管激菌症(HLH)是稀有的含重疾病,具有令人遗憾的细胞因子释放和继发性多用动量的衰竭,并且与高死亡率有关。主要HLH主要发生在具有遗传易感性的婴儿和幼儿中。获得的HLH表征较小,并且通常发生在较年轻的成年人中,在感染或恶性肿瘤引发的严重炎症中。对老年人来说,难题少。我们报告3名患者,50岁,在没有可识别的来源的情况下呈现多功能衰竭和休​​克,并最终被诊断为获得的HLH。我们在成人和GT的HLH进行了文献综述; 50岁,并确定了额外的68例。平均年龄为62岁,具有男性优势。大多数病例被感染(49%)触发,然后是恶性肿瘤(27%)。用HLH-94方案治疗19名患者,11个接受皮质类固醇,其余的接受非HLH特异性干预措施。总体死亡率为62%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号